Connect with us

Health

Rotary Donates $49.5m for Polio Eradication

Published

on

By Dipo Olowookere

With just 11 confirmed polio cases so far in 2017, the world is on the brink of eradicating polio, a vaccine-preventable disease that once paralyzed hundreds of thousands of children each year.

To recognize this historic progress, Rotary clubs worldwide says it will host events in conjunction with Rotary International’s fifth annual World Polio Day celebration on October 24.

This year, the event will be co-hosted by Rotary and the Bill & Melinda Gates Foundation and held at the foundation’s headquarters in Seattle.

The program will feature an update on the global fight to end polio and an array of guest speakers, celebrities, and public health experts. People around the world can view the livestream of the event on https://www.endpolio.org/world-polio-day on October 24 at 2:30pm Pacific time.

“Rotary and its partners are closer than ever to eradicating polio,” says Michael K. McGovern, chair of Rotary’s International PolioPlus Committee, which leads the organization’s polio eradication efforts. “World Polio Day is the ideal opportunity to celebrate our successes, raise public awareness, and talk about what is needed to end this paralyzing disease for good.”

Without full funding and political commitment to eradication, the disease could return to countries that are now polio-free and put children everywhere at risk. Rotary is giving $49.5 million in grants to support immunization and surveillance activities led by the Global Polio Eradication Initiative (www.PolioEradication.org).

Some of the funds will support efforts to end polio in the three countries where polio remains endemic: Afghanistan ($9.32 million), Pakistan ($8.94 million), and Nigeria ($7.71 million).

Further funding will support efforts to keep six vulnerable countries polio-free: Chad ($2.37 million), the Democratic Republic of Congo ($4.5 million), Guinea ($961,000), Somalia ($1.62 million), South Sudan ($3.77 million), and Sudan ($2.56 million).

An additional $7.74 million will go toward surveillance activities in Africa and the Eastern Mediterranean region.

In a show of solidarity and to raise awareness and funds for polio eradication, Rotary clubs around the globe will host nearly 1,900 events for World Polio Day.

They include a viewing party of the livestream in Fond du Lac, Wis; a Rock vs. Polio music event in Curitiba, Brazil; placing of End Polio Now piggy banks in local businesses to collect donations in Viljoenskroon, South Africa; a soccer game in Cairo, Egypt between the street children of Hope Village Society and students from local engineering colleges; and a golf fundraiser in Yoshiwara, Japan.

“To protect all children from polio, world governments and donors must see through their commitments to fund critical work and support rigorous disease surveillance in both endemic and at-risk polio-free countries,” says McGovern. Rotary has committed to raising $150 million over the next three years, which will be matched 2-to-1 by the Bill & Melinda Gates Foundation, yielding $450 million for polio eradication activities, including immunization and surveillance.

Rotary started its polio eradication program PolioPlus (EndPolio.org) in 1985, and in 1988 became a partner in the Global Polio Eradication Initiative (PolioEradication.org), along with WHO, UNICEF, and the U.S. Centers for Disease Control and Prevention. The Bill & Melinda Gates Foundation later became a partner, too. Since the initiative launched, the incidence of polio has plummeted by more than 99.9 percent, from about 350,000 cases in 1988 to just 37 cases in 2016. Rotary has contributed a total of more than $1.7 billion — including matching funds from the Gates Foundation — and countless volunteer hours to protect more than 2.5 billion children in 122 countries from polio.

Dipo Olowookere is a journalist based in Nigeria that has passion for reporting business news stories. At his leisure time, he watches football and supports 3SC of Ibadan. Mr Olowookere can be reached via [email protected]

Click to comment

Leave a Reply

Health

FG Begins Vaccination Against Mpox in FCT, Six States

Published

on

Monkeypox mpox

By Adedapo Adesanya

The Federal Ministry of Health and Social Welfare through the National Primary Health Care Development Agency (NPHCDA) has commenced the vaccination against Monkeypox, now known as Mpox.

Business Post reports that Bayelsa, Rivers, Cross River, Akwa Ibom, Enugu, Benue, and the Federal Capital Territory, were selected as pilot states for the vaccination.

An average of 631 persons are expected to be vaccinated across the seven states with two doses of the Mpox vaccine. A buffer for 50 persons will be kept at the national in case of an upsurge in other states.

NPHCDA in a statement posted on its verified X account confirmed the exercise, stressing that the vaccination will help to protect communities and safeguarding health of the people.

In a related development, according to the latest update by the Nigeria Centre for Disease Control (NCDC), there are 1,442 suspected cases of Mpox from 36 states and the Federal Capital Territory, while the number of confirmed cases of the infection was 118 from 28 states and the FCT.

“To prevent the spread of Mpox, we strongly advise the public to avoid contact with animals that may carry the virus, including sick or dead animals in affected areas, avoid handling materials that have been in contact with infected animals, limit unnecessary physical contact with individuals who are infected, practice frequent handwashing with soap and water, and ensure that animal food products are thoroughly cooked before eating.

“It’s also important to use protective clothing and gloves when handling sick animals or their tissues. Similarly, health workers are advised to follow standard safety protocols including droplet precautions when treating patients, use protective equipment including masks, gloves, and gowns, during patient care, and be vigilant for symptoms of Mpox, especially fever and rash, among other measures.”

Continue Reading

Health

AXA Mansard Health Partners LUTH in Blood Donation Drive

Published

on

Axa Mansard

By Aduragbemi Omiyale

Over 250 pints of blood have been donated by AXA Mansard Health to the Lagos University Teaching Hospital (LUTH), Idi Araba.

The blood was donated by more than 100 employees of the leading health insurance company in Nigeria through its volunteering programme tagged AXA Hearts in Action.

The initiative is part of the company’s blood donation drive aimed at contributing to positive societal and environmental impacts through employee volunteering, and expertise related financial support and in-kind donations.

According to the Chief Client Officer of AXA Mansard, Ms Rashidat Adebisi, “Through the AHIA, our employees do not just give time to great causes; we work together for a better future.”

“We share our time, knowledge and expertise as a people with a shared purpose of acting for human progress by protecting what matters through initiatives like this,” she added.

Ms Adebisi said the blood drive is a shining example of the philosophy in action, where collective contributions serve as a reminder that true impact often involves giving more than just money. It’s about putting one’s heart in action – an idea embedded in AXA’s corporate culture.

On his part, the chief executive of AXA Mansard Health Limited, Mr Tope Adeniyi, said with hospitals frequently experiencing blood shortages, events like these serve as a lifeline for patients in need.

“We are proud to contribute to the local healthcare sector and provide much-needed support to hospitals such as LUTH, ensuring that they have resources essential to saving lives,” he added.

Also commenting, the Head of Corporate Services and Public Relations at LUTH, Omolola Olubukunola Fakeye, thanked the firm for the “generous support,” which has made a “meaningful difference to our blood bank and ultimately to the lives of patients.”

“Blood donations are invaluable in many critical treatments, and initiatives like AXA Mansard’s blood drive bring immense relief to healthcare system.

“We are sincerely grateful for this partnership and the dedication of AXA Mansard’s employees,” Fakeye stated.

AXA Hearts in Action operates globally, she urging AXA employees everywhere to engage with and give back to their communities.

Through diverse projects – from health initiatives like this blood drive and medical outreaches to environmental efforts like the AXA Week for Good “Trash-to-Treasure” waste management project – AXA staff have opportunities to make a lasting difference on issues that matter.

For AXA Mansard, every act of social service brings them closer to the communities they serve, helping build a world where giving back is not only about charity but about lasting, positive change.

Continue Reading

Health

US Buys 4.8 million Swipha Malaria Doses for Nigeria, Others

Published

on

Swipha

By Adedapo Adesanya

The US Agency for International Development (USAID) has committed $2.3 million to procure 4.8 million doses of life-saving malaria tablets from Swiss Pharma (Swipha) in a landmark partnership that will expand access to essential medicines in Nigeria and West Africa.

This procurement, to be facilitated through the U.S. Government’s President’s Malaria Initiative (PMI), underscores the United States’ dedication to advancing Nigeria’s healthcare infrastructure and ensuring life-saving treatments reach vulnerable communities.

For years, Nigeria has faced significant challenges in procuring affordable, high-quality medicines due to the high cost of production and the inability of many local pharmaceutical companies to meet international quality standards.

According to the World Health Organization (WHO), fewer than 10 per cent of medicines manufactured in sub-Saharan Africa meet global standards, limiting local companies’ ability to supply essential drugs and meet healthcare needs.

These barriers have particularly affected access to medicines for malaria and child health, as local production has often fallen short of both quality and quantity requirements.

In response, USAID partnered with Swipha in their efforts to attain World Health Organization (WHO) prequalification for sulfadoxine/pyrimethamine (SP) tablets, a vital medicine for malaria prevention during pregnancy.

Swipha is now the first pharmaceutical company in Nigeria and in West Africa to achieve this WHO certification, marking a critical step forward for the region’s pharmaceutical capacity.

“USAID’s support was pivotal in helping us reach this milestone,” said Swipha Managing Director, Mr Frederic Lieutaud.

“The WHO prequalification not only validates our commitment to producing high-quality medicines but also enhances our capacity to scale production and serve both local and international markets with trusted, essential medicines.”

With the WHO prequalification, Swipha is well-positioned to expand its reach, supplying these essential medicines to international donors and procurement agencies, ultimately strengthening healthcare delivery across Nigeria and the broader West African region.

This achievement also represents a significant boost to Nigeria’s healthcare system by enhancing local manufacturing capacity and contributing to public health efforts to combat preventable diseases.

During her visit to Swipha’s facility in Lagos, USAID Mission Director to Nigeria, Ms Melissa Jones, commented “This achievement is a testament to the power of collaboration in improving healthcare in Nigeria.

“We are proud to have supported Swipha in reaching this milestone and look forward to continuing our partnership to ensure more quality medicines reach those who need them most. Together, we are building a healthier future for Nigeria.”

Continue Reading

Trending